Cargando…
Efficacy and safety of Qixue Tongzhi Granule in improving the exercise capacity of stable coronary artery disease: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
BACKGROUND: Despite optimal medical therapy, patients with stable coronary artery disease (SCAD) still have a high risk of recurrent cardiovascular events. Exercise capacity measured by cardiopulmonary exercise testing (CPET) is a good surrogate marker for the long-term prognosis of SCAD. Qixue Tong...
Autores principales: | Chao, Tiantian, Sun, Jinghui, Huan, Na, Ge, Yaru, Wang, Chenglong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470462/ https://www.ncbi.nlm.nih.gov/pubmed/37663413 http://dx.doi.org/10.3389/fcvm.2023.1186018 |
Ejemplares similares
-
Qixue Shuangbu decoction and acupuncture combined with Western medicine in acute severe stroke patients
por: Gou, Li-Kun, et al.
Publicado: (2023) -
Refractory angina pectoris: a 20-year (2003–2022) bibliometric analysis
por: Chen, Yunru, et al.
Publicado: (2023) -
Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial
por: Wu, Xiaoping, et al.
Publicado: (2022) -
A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease
por: Wang, Yiru, et al.
Publicado: (2019) -
A multi-center, randomized, double-blinded, parallel, placebo-controlled study to assess the efficacy and safety of Shenqisuxin granule in complex coronary artery disease after PCI: Study protocol
por: Wu, Xiaoping, et al.
Publicado: (2022)